tert-butyl N-(2-cyanoallyl)carbamate

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: tert-butyl N-(2-cyanoallyl)carbamate
• 英文别名: tert-butyl N-(2-cyanoprop-2-enyl)carbamate
• 化学式: C₉H₁₄N₂O₂
• 分子量: 182.222
• InChiKey: UZPYKRKKYFCMQI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  62.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  tert-butyl N-(2-cyanoallyl)carbamate 在 Rh(I)-(R,R)-Et-DuPHOS 、 氢气 作用下， 以 甲醇 为溶剂， 20.0 ℃ 、413.68 kPa 条件下， 反应 24.0h， 以91%的产率得到t-butyl N-(2'-cyanopropyl)carbamate
  参考文献：
  名称：

  A new enantioselective synthesis of β-amino acids

  摘要：

  Enantioselective hydrogenation of some alpha,beta -unsaturated nitriles and their corresponding methyl esters bearing a phthalimidomethyl substituent at the alpha -carbon using Rh-DuPHOS catalysts afforded beta -amino acid precursors with modest e.e.s of up to 48%. Hydrogenation of the alpha,beta -unsaturated methyl esters using a Ru-BINAP catalyst gave higher e.e.s of up to 84%. Method development for the determination of the enantiomeric excesses of these derivatives using chiral HPLC is also reported. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0957-4166(01)00097-0
• 作为产物：
  描述：

  N-Boc-氨基丙炔 生成 tert-butyl N-(2-cyanoallyl)carbamate
  参考文献：
  名称：

  JACKSON, W. ROY;PERIMUTTER, PATRICK;SMALLRIDGE, ANDREW J., AUSTRAL. J. CHEM., 41,(1988) N, C. 1201-1208

  摘要：

  DOI：

文献信息

• [EN] METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION<br/>[FR] MÉTHODES ET COMPOSÉS POUR LA RESTAURATION D'UNE FONCTION DE MUTANTS DE P53
  申请人：PMV PHARMACEUTICALS INC

  公开号：WO2021262596A1

  公开（公告）日：2021-12-30

  Mutations in oncogenes and tumor suppressors contribute to the development and progression of cancer. The present disclosure describes compounds and methods that restore DNA binding affinity of p53 mutants. The compounds of the present disclosure can bind to mutant p53 and restore the ability of the p53 mutant to bind DNA and activate downstream effectors involved in tumor suppression. The disclosed compounds can be used to reduce the progression of cancers that contain a p53 mutation.

  癌基因和肿瘤抑制基因的突变促进了癌症的发展和进展。本公开描述了一种恢复p53突变体DNA结合亲和力的化合物和方法。本公开的化合物可以结合突变的p53，并恢复p53突变体结合DNA和激活与肿瘤抑制有关的下游效应子的能力。公开的化合物可用于减少含有p53突变的癌症的进展。
• JACKSON, W. ROY;PERIMUTTER, PATRICK;SMALLRIDGE, ANDREW J., AUSTRAL. J. CHEM., 41,(1988) N, C. 1201-1208
  作者：JACKSON, W. ROY、PERIMUTTER, PATRICK、SMALLRIDGE, ANDREW J.

  DOI：——

  日期：——
• [EN] PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS<br/>[FR] COMPOSITIONS PHARMACEUTIQUES COMPRENANT DES INHIBITEURS DE L'HÉLICASE WRN
  申请人：[en]VIVIDION THERAPEUTICS, INC.

  公开号：WO2024010782A1

  公开（公告）日：2024-01-11

  Disclosed are compounds of Formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R1, R3, X, Y, Z, and W arc as defined herein. The compounds are, for example, inhibitors of WRN helicase and useful in treating a proliferative disease, such as cancer.
• A new enantioselective synthesis of β-amino acids
  作者：Dilek Saylik、Eva M. Campi、Andrew C. Donohue、W.Roy Jackson、Andrea J. Robinson

  DOI：10.1016/s0957-4166(01)00097-0

  日期：2001.3

  Enantioselective hydrogenation of some alpha,beta -unsaturated nitriles and their corresponding methyl esters bearing a phthalimidomethyl substituent at the alpha -carbon using Rh-DuPHOS catalysts afforded beta -amino acid precursors with modest e.e.s of up to 48%. Hydrogenation of the alpha,beta -unsaturated methyl esters using a Ru-BINAP catalyst gave higher e.e.s of up to 84%. Method development for the determination of the enantiomeric excesses of these derivatives using chiral HPLC is also reported. (C) 2001 Elsevier Science Ltd. All rights reserved.